TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Gambogic Acid, Sunitinib
Phytochemical Name Gambogic Acid (PubChem CID: 9852185 )
Anticancer drug Name Sunitinib (PubChem CID: 5329102 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 883
Pair Name Gambogic Acid, Sunitinib
Disease Info [ICD-11: 2C90.0] Renal cell carcinoma Investigative
Biological Phenomena Inhibition-->Angiogenesis
Gene Regulation Down-regulation Expression BCL2 hsa596
Up-regulation Expression CDKN1A hsa1026
Down-regulation Expression VEGFA hsa7422
In Vitro Model 786-O Renal cell carcinoma Homo sapiens (Human) CVCL_1051
Caki-1 Clear cell renal cell carcinoma Homo sapiens (Human) CVCL_0234
In Vivo Model Caki-1 cells (2×10⁶) in 100 ul RPMI-1640 and 100 ul of matrigel were used to inject subcutaneously into each mouse (5-week-old male athymic BALB/c nu/nu mice).
Result Our results show that the joint use of GA and SU can provide greater antitumor efficacy compared to either drug alone and thus may offer a new treatment strategy for renal cell carcinoma.
03. Reference
No. Title Href
1 Targeting renal cell carcinoma with gambogic acid in combination with sunitinib in vitro and in vivo. Asian Pac J Cancer Prev. 2012;13(12):6463-8. doi: 10.7314/apjcp.2012.13.12.6463. Click
It has been 46305 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP